Background
==========

Staphylococci inhabit the skin and mucous membranes of animals and humans. Due to the ability to produce biofilm, they are also a common cause of device-associated infections \[[@B1]-[@B4]\]. Biofilm formation capacity is associated with antimicrobial resistance, and considered widely as a virulence factor. Invasive isolates are more prone to produce biofilm than carriage isolates of healthy individuals \[[@B5],[@B6]\]. *Staphylococcus epidermidis*was the first species to be described as a biofilm producer; however, the same ability is encountered in *S. aureus*and other coagulase-negative *Staphylococcus*species \[[@B7],[@B8]\].

The principal component of biofilm is a polysaccharide intercellular adhesin {PIA} \[[@B9],[@B10]\]. PIA is composed of a beta-1,6-N-acetylglucosamine polymer synthesized by an enzyme codified by the *ica*operon found on the bacterial chromosome, that includes a regulating element of four genes (*A, B, C*, and *D*), and a transposable element, *IS*256 \[[@B11]\]. It is known that the *A*gene codifies the N-acetylglucosamyl transferase enzyme responsible for synthesizing PIA. This enzyme is not very active *in vitro*, but co-expression of the *D*gene increases the activity. *IcaB*is the deacetylase responsible for the de-acetylation of mature PIA and the transmembrane protein *IcaC*seems to be involved in externalization and elongation of the growing polysaccharide \[[@B9],[@B12]\].

The expression of the *icaADBC*genes is controlled by a complex variety of conditions and factors; one of them is the excision or insertion of the bacterial sequence element IS*256*at various locations on the operon. The molecular basis for the regulation process is still unclear; however, the insertion element is definitely responsible for up to 33% of the activated portion of the operon that allows its expression \[[@B1],[@B10],[@B13],[@B14]\]. Other regulator genes (*Rsb*U, σ^B^, *Tca*-R, *agr, sarA*) for PIA production have also been reported \[[@B15]\].

Biofilm production usually occurs in two steps, 1) the initial step of adhesion to the surface, facilitated by adhesive polysaccharides and/or a polysaccharide with multiple proteins (including autolysins), and 2) the accumulation of cells due to PIA production, synthesized after activation of the *ica*operon \[[@B9]\]. Initial findings assumed that the presence of ica*ADBC*genes will contribute to the persistence of infection and therapeutic failure in presence of a medical device. Some authors have tried to establish the presence of the *AD*genes as a prognosis biomarker in device associated infections \[[@B8],[@B16]\]. Many other environmental conditions and the phenotype of the *Staphylococcus*isolate also participate in the regulation of biofilm production \[[@B17]\]. By understanding the different mechanisms of biofilm production it will be possible to support the development of therapeutic strategies \[[@B5]\].

The objective of this study was to describe the association between biofilm production, the presence of *icaADBC*genes, the bacterial insertion sequence IS*256*and therapeutic failure, in isolates from patients with medical device-related infections.

Methods
=======

Clinical staphylococci isolates were collected prospectively from hospitalized patients with a staphylococcal medical device-related infection from September 2002 to July 2003. Isolates were obtained from blood, cerebrospinal fluid and peritoneal fluid. The protocol was approved by the Institutional Review Board. Patient\'s data were obtained from clinical records. Infection was defined in accordance with internationally proposed criteria \[[@B18]\].

Empirical antimicrobial treatment was prescribed for all patients, and was modified according to susceptibility patterns.

Therapeutic failure was considered:

1\) For central venous catheter (CVC) related bacteremia/sepsis, persistence of positive blood cultures collected through the CVC after 72 hours of administering proper antimicrobial treatment.

2\) For peritonitis, persistence of positive peritoneal fluid culture collected through peritoneal dialysis catheter or a cellularity ≥ 100 cells per mm^3^after 72 hours of administering proper antimicrobial treatment.

3\) For ependymitis, after removal of the infected shunt, persistence of positive cerebrospinal fluid (CSF) culture collected through external ventriculostomy, after 72 hours of systemic and/or intraventricular antimicrobial treatment.

Microbiology
------------

*Staphylococcus*species were identified by API-Staph system (bioMérieux). Antimicrobial susceptibility was determined in accordance with CLSI recommendations, oxacillin resistant isolates were tested for *mec*A gene by PCR \[[@B19],[@B20]\].

The isolates were characterized phenotipically by culture on Congo red agar plates (CRA) as described by Freeman et al. \[[@B21]\], with modifications as described by Arciola et al \[[@B22]\]: agar plates were prepared with 0.8 g of CRA (Sigma) and 36 g of saccharose (Sigma) to 1 liter of brain heart infusion agar (Dibico, Mexico) and incubated 24 h at 37°C and subsequently overnight at room temperature. For *S. aureus*CRA were kept up to 72 h.

The quantitative assay by Christensen was used to test the ability to produce biofilm \[[@B23]\]. Briefly, 1:100 dilutions of overnight cultures in trypticase soy broth were used to inoculate wells in a microtiter polystyrene plate (Falcon, Becton Dickinson, Labware, NJ, USA). After incubation for 24 h at 37°C, the plates were gently washed two times with phosphate-buffered saline (PBS, 10 mM potassium phosphate, 0.15 M NaCl pH 7.0), and stained with 1% (w/v) crystal violet solution; the excess stain was washed off with demineralised water. The adherent cells were resuspended in acid-isopropanol (5% v/v 1 M HCl in isopropanol), and the absorbance (A) was measured at 492 nm in a microplate reader. A biofilm producer strain was defined as an optical density at 492 nm of ≥ 0.17. Clonal relatedness of strains was excluded using Pulsed Field Gel Electrophoresis (PFGE) \[[@B24]\].

The presence of the *A, B, C*, and *D*genes of the *ica*operon and the position of the bacterial sequence element IS*256*were detected by PCR according to the protocol described by de Silva G. \[[@B6]\] with some modifications: DNA extraction was performed with the Promega^®^Wizard Genomic Kit (Madison, WI, USA). Primer sequences were taken from the GenBank sequence database of the National Center for Biotechnology Information \[GenBank accession number [U43366](U43366) for *S. epidermidis*, [EF546621](EF546621) for *S. lugdunensis*\]. The sequence for the bacterial insertion element was taken from the publication by Ziebuhr \[[@B25]\].

The PCR cycling conditions used were 30 cycles of 1 min of denaturation at 94°C and 2.5 min of elongation at 72°C for all reactions, with annealing for 1 min at 60°C (i*caA*), 59°C (*icaB*), 45°C (*icaC*), 59°C (*icaD*), or 59°C (IS*256*). After amplification in a T-personal thermocycler (Whatman Biometra GmbH, Göttingen, Germany), 5 μl of the PCR mixture was used in analysis for horizontal electrophoresis in agarose gel of up to 2% tris-borate-EDTA. A 100 bp ladder DNA molecular weight marker was used. Samples with positive amplification for the *A*and *D*fragments were analyzed for the presence of the insertion element IS*256*, amplifying the sequence by PCR (Table [1](#T1){ref-type="table"}). *S. aureus*ATCC 29247 and *S. epidermidis*ATCC 35984 (RP62A) were used as negative and positive controls.

###### 

Primer sequences for PCR used in this study.

  ----------------------------------------------------------------------------------------
  Primer            Sequence (5\'-3\')                Product size (bp)   PCR conditions
  ----------------- --------------------------------- ------------------- ----------------
  *icaA*forward\    GAC CTC GAA GTC AAT AGA GGT\      814                 30 s 95°C\
  *icaA*reverse     CCC AGT ATA ACG TTG GAT ACC                           60 s 60°C\
                                                                          90 s 72°C

  *icaB*forward\    ATG GCT TAA AGC ACA CGA CGC\      526                 60 s 95°C\
  *icaB*reverse     TAT CGG CAT CTG GTG TGA CAG                           60 s 59°C\
                                                                          90 s 72°C

  *icaC*forward\    ATA AAC TTG AAT TAG TGT ATT\      989                 30 s 95°C\
  *icaC*reverse     ATA TAT AAA ACT CTC TTA ACA                           60 s 42°C\
                                                                          90 s 72°C

  IS*256*forward\   TGA AAA GCG AAG AGA TTC AAA GC\   1102                60 s 94°C\
  IS*256*reverse    ATG TAG GTC CAT AAG AAC GGC                           60 s 59°C\
                                                                          90 s 68°C

  *icaD*forward\    AGG CAA TAT CCA ACG GTA A\        371                 60 s 94°C\
  *icaD*reverse     GTC ACG ACC TTT CTT ATA TT                            60 s 59°C\
                                                                          150 s 72°C
  ----------------------------------------------------------------------------------------

Only one strain of each infection episode was included for analysis.

Statistical analysis
--------------------

To compare differences between groups Mantel-Haenszel *x*^2^or Fisher exact test were employed, a value of p \< 0.05 was considered to be significant. Statistical analysis was performed with SPSS for Windows software version 11.0.

Results
=======

During the study period, one hundred isolates from patients with diagnosis of device-related infections were included. The episodes were divided in 40 CVC-related bacteremias, 32 ependymitis, and 28 peritonitis. *S. epidermidis*was isolated in 45 episodes, *S. aureus*in 39 and diverse coagulase negative *Staphylococcus*(CoNS)non-*epidermidis*in 16 (*S. hominis, S. haemolyticus, S. lugdunensis, S. auricularis, S. warnerii*and *S. sciurii*). 33% of the isolates were oxacillin-resistant, 31% were resistant to amikacin, 26% to norfloxacin and 0% to vancomycin. According to the PFGE results, all the strains included corresponded to a different genotype.

Biofilm production was confirmed in 22 strains by the Christensen assay, of these, 19 had a positive phenotype on the CRA plates. *IcaADBC*genes and the bacterial insertion sequence IS*256*were detected in most of the strains, except for two strains of *S. auricularis*, one *S. warnerii*and one *S. sciurii*. 73.77% of CoNS and 79.5% of *S. aureus*isolates harbored the *icaD*gene; *icaA, icaB*and *icaC*genes were present in 27.8%, 21.3% and 9.8% of CoNS isolates (Table [2](#T2){ref-type="table"}, figure [1](#F1){ref-type="fig"}). Only 4/39 *S. aureus*isolates were positive for *icaA+IcaD*genes but none for the bacterial insertion sequence. *IS*256-A+ *IS*256-D genes were detected in 21/45 *S. epidermidis*and 6/16 non-*epidermidis*CoNS. (figure [2](#F2){ref-type="fig"}, figure [3](#F3){ref-type="fig"}).

###### 

*IcaADBC*genes and bacterial insertion element IS*256*in *Staphylococcus*spp. isolates from device-related infections.

  Microorganism       No. isolates   *IcaA*   *IcaB*   *IcaC*   *IcaD*   *IcaA*+ *IcaD*   IS*256-A*/IS*256-D*
  ------------------- -------------- -------- -------- -------- -------- ---------------- ---------------------
  *S. epidermidis*    45             23       11       4        39       22               21
  *S. aureus*         39             4        0        0        31       4                0
  *S. hominis*        6              4        0        0        6        4                3
  *S. haemolyticus*   4              1        1        1        2        2                2
  *S. lugdunensis*    2              1        1        1        1        1                1
  *S. auricularis*    2              0        0        0        0        0                0
  *S. warnerii*       1              0        0        0        0        0                0
  *S. sciurii*        1              0        0        0        0        0                0

![**Electrophoresis of PCR products with primers for IS*256*and *icaA***. Lane 1, 100 bp molecular weight marker; lane 2, negative control; lane 3, 814-bp band from *icaA*positive control; lane 4 and lane 5, negative samples; lane 6, 814-bp band from *S. aureus*strain; lane 7, 1102-bp band (IS*256*) and 814-bp band (*icaA*) from *S. epidermidis*strain; lane 8, 1102-bp band from IS*256*positive control; lane 9, lane 10 and lane 11, 1102-bp bands (IS*256*) and 814-bp bands (*icaA*) from *S. epidermidis*strains.](1471-2334-10-68-1){#F1}

![**Electrophoresis of PCR products with primers for i*caC***. Lane 1, 100 bp molecular weight marker; lane 2, 989-bp band from *icaC*positive control; lane 3, negative control; lane 4, negative sample; lane 5 and lane 6, 989-bp bands (*icaC*) from *S. epidermidis*strains.](1471-2334-10-68-2){#F2}

![**Electrophoresis of PCR products with primers for IS*256*and i*caD***. Lane 1, 100 bp molecular weight marker; lane 2, 371-bp band from i*caD*positive control; lane 3 and lane 4, 371-bp bands (i*caD*) from *S. haemolyticus*strains; lane 5, 1102-bp band (IS*256*) and 371-band (i*caD*) from *S. haemolyticus*strain; lane 6, 371-bp band (i*caD*) from *S. haemolyticus*strain; lane 7, 1102-bp band (IS*256*) and 371-band (i*caD*) from *S. haemolyticus*strain; lane 8, 371-band (i*caD*) from *S. haemolyticus*strain.](1471-2334-10-68-3){#F3}

Therapeutic failure in episodes caused by an *IS*256-A+ *IS*256-D positive strain was 95.4% for *S. epidermidis*, RR 5.49 (CI 95% 2.24-13.44, p ≤ 0.0001), and 85.76% in CoNS isolates, RR 2.57 (CI 95% 0.97-6.80, p = 0.05). Although none *S. aureus*was positive for *IS*256-A + *IS*256-D, therapeutic failure was observed in 35.8%. (Table [3](#T3){ref-type="table"}).

###### 

*IcaAD*genes, bacterial sequence element and risk for therapeutic failure.

  ---------------------------------------------------------------------------------------------------------------
  Microorganism\                 *IcaAD*genes     Bacterial sequence element   Failure    Risk
  (No. isolates)                                                                          
  ------------------------------ ---------------- ---------------------------- ---------- -----------------------
  *S. epidermidis*\              *icaA + icaD*\   IS*256-A/*\                  21/22\     RR 5.49 (2.24-13.44)\
  (45)                           22               IS*256-D*\                   vs 4/23    p \< 0.0001\*
                                                  21                                      

  Non-*S. epidermidis*CoNS^&^\   *icaA + icaD*\   IS *256-A*/\                 6/7\       RR 2.57 (0.97-6.80)\
  (16)                           7                IS *256-D*\                  vs 3/9     p = 0.05\*\*
                                                  6                                       

  *S. aureus*\                   *icaA + icaD*\   IS*256-A/*\                  2/4\       RR 1.35 (0.46-3.93)\
  (39)                           4                IS*256-D*\                   vs 13/35   p = 0.5\*\*
                                                  -                                       
  ---------------------------------------------------------------------------------------------------------------

^&^Coagulase-negative *Staphylococcus*. \*Mantel-Haenszel square-chi. \*\*Fisher-exact test.

Discussion
==========

Biofilm production has been clearly linked to infections in the presence of foreign bodies for various decades \[[@B26]\], it has been demonstrated *in vivo*tests with laboratory animals and *in vitro*, that biofilm hampered thorough penetration of the antimicrobial and the concentrations require to eradicate biofilm-producing strains are higher than those required to eradicate strains that did not produce biofilm \[[@B27],[@B28]\].

In this study, as reported by other authors, it was found that the genes of the *Ica*operon frequently appeared in strains of *Staphylococcus epidermidis*\[[@B4],[@B6],[@B29]\]. The number of *S. aureus*isolates with a positive biofilm phenotype or producing biofilm was low (4/39), and in none of them the bacterial insertion element IS*256*was present. Experimental studies have also shown that biofilm formation is possible in *icaADBC*operon *S. aureus*mutants \[[@B30]\], but we did not find *S. aureus*negative for the operon that was a biofilm producer. *S. epidermidis*strains with the genetic determinant for biofilm formation were clearly associated to a high risk of therapeutic failure, which was not corroborated with non-*epidermidis*CoNS and *S. aureus*, perhaps due to a smaller number of collected isolates.

As previously stated, adhesion to the plastic device could be a factor linked to weaker expression of symptoms of infection, due to the existence of a smaller number of circulating bacteria, most of them remaining inside the catheter. This mild presentation could support the non-standard recommendation to preserve the medical device in patients with bacteremia. This is necessary in some cases due to the critical condition of the patient. However, the risk of failure to proper antimicrobial treatment is so high, that this conduct should be avoided and the CVC removed as soon as possible, even if a negative *icaA +IcaD*isolate is detected.

The present work has several limitations. Infections included are difficult to compare to elicit general recommendations, in particular for the ependymitis and peritonitis episodes. The *ica*operon genes have been widely described in *Staphylococcus epidermidis*and *Staphylococcus aureus*, several authors have found similarity in other CoNs species \[[@B6],[@B7]\] but results cannot be extended to all pathogenic species. Recently biofilm formation has been described in detail in *S. haemolyticus*isolates \[[@B31]\]. Phenotypic variation as well as clonal lineage must be included in future studies to develop alternative therapeutic strategies.

Conclusions
===========

The presence of *icaA/D*genes along with the sequence element *IS*256 was associated with therapeutic failure in most CoNS infections, even though its absence in *S. aureus*isolates does not ensure therapeutic success.
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